LACTOSE (INDIA)
Back to Balance Sheet
|
LACTOSE (INDIA) Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹2.32 Cr | ₹1.90 Cr | ₹0.68 Cr | ₹0.58 Cr | ₹0.46 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of LACTOSE (INDIA) ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹2.32 Cr |
| Mar2024 | ₹1.90 Cr |
| Mar2023 | ₹0.68 Cr |
| Mar2022 | ₹0.58 Cr |
| Mar2021 | ₹0.46 Cr |
How is Deferred Tax Assets / Liabilities of LACTOSE (INDIA) Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹2.32 Cr | 22.20 | |
| Mar2024 | ₹1.90 Cr | 179.15 | |
| Mar2023 | ₹0.68 Cr | 17.41 | |
| Mar2022 | ₹0.58 Cr | 26.64 | |
| Mar2021 | ₹0.46 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of LACTOSE (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LACTOSE (INDIA) | ₹128.3 Cr | 5.6% | 1.6% | 6.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,870.0 Cr | 0.8% | 6.3% | 18.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹220,946.0 Cr | 8.6% | 20.7% | 18.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,907.0 Cr | 1.7% | 9.4% | 38.5% | Stock Analytics | |
| CIPLA | ₹118,674.0 Cr | 4.5% | 1.2% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,648.7 Cr | -0.3% | -14.8% | -9.5% | Stock Analytics | |
LACTOSE (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LACTOSE (INDIA) | 5.6% |
1.6% |
6.1% |
| SENSEX | 2.4% |
1.5% |
-4.3% |
You may also like the below Video Courses